“We can then turn those cells into beating heart cells and use them later in treating congenital heart defects,” Jeffrey Jacot, associate professor of pediatrics and bioengineering at the University of Colorado Center for Bioengineering in the CU School of Medicine and the study’s senior author, said in a news release. “These results allow for an expanded and readily available source of amniotic stem cells beyond traditional collection through amniocentesis.”